DLD Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-103,800
Closed -$6.36M 64
2017
Q3
$6.36M Buy
+103,800
New +$6.36M 0.63% 14